← Back to headlines
Nautilus Outlines Cash Runway and R&D Shift Towards Proteoform Assays
Nautilus projects its cash runway into Q1 2028 and plans to shift its R&D focus towards approximately 20 proteoform assays by mid-2028.
28 Jul, 17:24 — 28 Jul, 17:24
Sources
Showing 1 of 1 sources
